283 related articles for article (PubMed ID: 30988616)
1. In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications.
Hua S; Vaughan B
Int J Nanomedicine; 2019; 14():2191-2206. PubMed ID: 30988616
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and
Hua S
J Liposome Res; 2019 Dec; 29(4):357-367. PubMed ID: 30526169
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor.
Paul JW; Hua S; Ilicic M; Tolosa JM; Butler T; Robertson S; Smith R
Am J Obstet Gynecol; 2017 Mar; 216(3):283.e1-283.e14. PubMed ID: 27567564
[TBL] [Abstract][Full Text] [Related]
4. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
[TBL] [Abstract][Full Text] [Related]
5. Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation.
Kang MJ; Park SH; Kang MH; Park MJ; Choi YW
Int J Nanomedicine; 2013; 8():1155-65. PubMed ID: 23515421
[TBL] [Abstract][Full Text] [Related]
6. Effect of oxytocin receptor and beta2-adrenoceptor blockade on myometrial oxytocin receptors in parturient rats.
Engstrøm T; Bratholm P; Vilhardt H; Christensen NJ
Biol Reprod; 1999 Feb; 60(2):322-9. PubMed ID: 9915997
[TBL] [Abstract][Full Text] [Related]
7. The regulation of oxytocin receptor expression in human myometrial monolayer culture.
Adachi S; Oku M
J Smooth Muscle Res; 1995 Aug; 31(4):175-87. PubMed ID: 8589505
[TBL] [Abstract][Full Text] [Related]
8. Coupling of oxytocin receptor to G proteins in rat myometrium during labor: Gi receptor interaction.
Strakova Z; Soloff MS
Am J Physiol; 1997 May; 272(5 Pt 1):E870-6. PubMed ID: 9176188
[TBL] [Abstract][Full Text] [Related]
9. Tumor targeting using anti-her2 immunoliposomes.
Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
[TBL] [Abstract][Full Text] [Related]
10. Effects of RU486 on estrogen, progesterone, oxytocin, and their receptors in the rat uterus during late gestation.
Fang X; Wong S; Mitchell BF
Endocrinology; 1997 Jul; 138(7):2763-8. PubMed ID: 9202215
[TBL] [Abstract][Full Text] [Related]
11. A novel anti-VEGF165 monoclonal antibody-conjugated liposomal nanocarrier system: physical characterization and cellular uptake evaluation in vitro and in vivo.
Shi C; Gao F; Gao X; Liu Y
Biomed Pharmacother; 2015 Feb; 69():191-200. PubMed ID: 25661357
[TBL] [Abstract][Full Text] [Related]
12. Development of a Rapidly Dissolvable Oral Pediatric Formulation for Mefloquine Using Liposomes.
Tang WL; Tang WH; Chen WC; Diako C; Ross CF; Li SD
Mol Pharm; 2017 Jun; 14(6):1969-1979. PubMed ID: 28460165
[TBL] [Abstract][Full Text] [Related]
13. GPIIb/IIIa Receptor Targeted Rutin Loaded Liposomes for Site-Specific Antithrombotic Effect.
Priya V; Singh SK; Revand R; Kumar S; Mehata AK; Sushmitha P; Mahto SK; Muthu MS
Mol Pharm; 2023 Jan; 20(1):663-679. PubMed ID: 36413707
[TBL] [Abstract][Full Text] [Related]
14. RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
Kang MH; Park MJ; Yoo HJ; hyuk KY; Lee SG; Kim SR; Yeom DW; Kang MJ; Choi YW
Eur J Pharm Biopharm; 2014 Aug; 87(3):489-99. PubMed ID: 24704199
[TBL] [Abstract][Full Text] [Related]
15. Iridium (III) complex-loaded liposomes as a drug delivery system for lung cancer through mitochondrial dysfunction.
Liao C; Xu D; Liu X; Fang Y; Yi J; Li X; Guo B
Int J Nanomedicine; 2018; 13():4417-4431. PubMed ID: 30104875
[TBL] [Abstract][Full Text] [Related]
16. Current data on ATP-containing liposomes and potential prospects to enhance cellular energy status for hepatic applications.
Korb V; Tep K; Escriou V; Richard C; Scherman D; Cynober L; Chaumeil J; Dumortier G
Crit Rev Ther Drug Carrier Syst; 2008; 25(4):305-45. PubMed ID: 18540841
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
[TBL] [Abstract][Full Text] [Related]
18. Bacteria-targeting liposomes for enhanced delivery of cinnamaldehyde and infection management.
Sang N; Jiang L; Wang Z; Zhu Y; Lin G; Li R; Zhang J
Int J Pharm; 2022 Jan; 612():121356. PubMed ID: 34919996
[TBL] [Abstract][Full Text] [Related]
19. Future directions of liposome- and immunoliposome-based cancer therapeutics.
Park JW; Benz CC; Martin FJ
Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
[TBL] [Abstract][Full Text] [Related]
20. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.
Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C
Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
